NEOGEN CORP — fact timeline

Thierry Bernard resigned as Director at NEOGEN CORP.

“On August 3, 2026, Mr. Thierry Bernard resigned from the Board of Directors of Neogen Corporation.”

NEOGEN CORP reported third quarter ended February 28, 2026 results: revenue $211.2 million, net income Net loss of $17.0 million, EPS GAAP EPS of $(0.08). Guidance raised.

“language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Reports Third Quarter Fiscal Year 2026 Financial Results • Fiscal third quarter 2026 revenue of $211.2 million • Food Safety revenue growth of 2.6%, Core Growth 1 of 4.0%; Animal Safety revenue growth of (20.1%), Core Growth 1 of (8.7%) due primarily to third-party supplier challenges in”

Andrea Wainer was appointed as Director at NEOGEN CORP.

“Replacing Mr. Tobin, Neogen appoints Andrea Wainer to Neogen’s Board of Directors, effective June 1, 2025.”

James P. Tobin retired as Director at NEOGEN CORP.

“announces that James P. Tobin has chosen to retire from the Company’s Board of Directors, effective May 31, 2025.”

John Adent departed as CEO and President at NEOGEN CORP.

“On April 9, 2025 Neogen Corporation (the “Company”) announced that John Adent, the Company’s CEO and President, will be stepping down.”

Doug Jones departed as Chief Operating Officer at NEOGEN CORP.

“Doug Jones, who will be retiring as Chief Operating Officer effective February 28, 2025”

David Naemura was appointed as Chief Operating Officer at NEOGEN CORP.

“David Naemura has been appointed Chief Operating Officer effective January 1, 2025, in addition to his role as Chief Financial Officer.”

Douglas E. Jones departed as Chief Operating Officer at NEOGEN CORP.

“Douglas E. Jones, Neogen’s Chief Operating Officer, has communicated his intent to retire in early 2025.”

Thierry Bernard was appointed as Director at NEOGEN CORP.

“Neogen Corporation announced today that it has appointed Thierry Bernard to its Board of Directors.”

NEOGEN CORP reported fiscal 2024 third quarter ended February 29, 2024 results: revenue $228.8 million, net income $(2.0) million; $(0.01) per diluted share, EPS $(0.01) per diluted share. Guidance lowered.

“regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces Third-Quarter 2024 Results • Revenue of $228.8 million. • Net loss of $(2.0) million; $(0.01) per diluted share. • Adjusted Net Income of $26.4 million; $0.12 per diluted share. • Adjusted EBITDA of $52.7 million. • Updating”

David Naemura changed role as Chief Financial Officer at NEOGEN CORP.

“David Naemura will continue as the Company’s Chief Financial Officer and Mr. Moylan will serve as the Company’s Principle Accounting Officer, replacing Mr. Naemura in that role.”

John Moylan was appointed as Vice President, Corporate Controller, and Chief Accounting Officer at NEOGEN CORP.

“John Moylan is appointed as Vice President, Corporate Controller, and Chief Accounting Officer of Neogen Corporation (the “Company”) effective April 15, 2024.”

NEOGEN CORP reported second quarter ended November 30, 2023 results: revenue Revenue of $229.6 million., net income Net loss of $3.5 million; $(0.02) per diluted share.. Guidance reaffirmed.

“regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces Second-Quarter 2024 Results • Revenue of $229.6 million. • Net loss of $3.5 million; $(0.02) per diluted share. • Adjusted Net Income of $24.9 million; $0.11 per diluted share. • Adjusted EBITDA of $55.1 million, at a margin of 24.0%.”

NEOGEN CORP: Board approved amended and restated bylaws effective October 26, 2023, updating governance provisions including virtual meetings, shareholder nomination procedures, and officer powers (effective 2023-10-26).

“On October 26, 2023, the Board of Directors of the Company approved the amended and restated bylaws (the bylaws, as so amended and restated, the “Amended and Restated Bylaws”), effective immediately.”

NEOGEN CORP shareholders approved Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm at the 2023-10-25 meeting.

“Proposal 5 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm The shareholders ratified the appointment of BDO USA, P.A. as the Company’s auditors for the fiscal year ending May 31, 2024. For Against Abstain Broker Non-Vote 192,927,257 10,053,877 119,983 -”

NEOGEN CORP shareholders approved To Approve the Establishment of the Neogen Corporation 2023 Omnibus Incentive Plan at the 2023-10-25 meeting.

“Proposal 4 – To Approve the Establishment of the Neogen Corporation 2023 Omnibus Incentive Plan The shareholders approved the establishment of the Neogen Corporation 2023 Omnibus Incentive Plan, as disclosed in the proxy materials. For Against Abstain Broker Non-Vote 183,704,273 11,662,966 268,951 7,464,927”

NEOGEN CORP shareholders approved To Approve, on an Advisory Basis, the Frequency of Future Advisory Votes on Executive Compensation at the 2023-10-25 meeting.

“Proposal 3 – To Approve, on an Advisory Basis, the Frequency of Future Advisory Votes on Executive Compensation The shareholders approved, on an advisory basis, the frequency of future advisory votes on executive compensation, as disclosed in the proxy materials. 1 Year 2 Years 3 Years Abstain 194,187,940 83,339 1,162,434 202,477”

NEOGEN CORP shareholders approved To Approve, by Non-Binding Vote, the Compensation of the Company’s Named Executive Officers at the 2023-10-25 meeting.

“Proposal 2 – To Approve, by Non-Binding Vote, the Compensation of the Company’s Named Executive Officers The shareholders approved, by non-binding vote, the compensation of the Company’s named executive officers, as disclosed in the proxy materials. For Against Abstain Broker Non-Vote 188,942,194 6,399,654 294,342 7,464,927”

NEOGEN CORP shareholders approved Election of Directors at the 2023-10-25 meeting.

“Proposal 1 – Election of Directors Nominee For Withheld Aashima Gupta 173,676,074 22,019,553 Raphael A. Rodriguez 187,452,904 8,242,723 Catherine E. Woteki, Ph.D. 190,787,923 4,907,704”

NEOGEN CORP reported fiscal 2024 first quarter ended August 31, 2023 results: revenue $229.0 million, net income $1.5 million, or $0.01 per diluted share. Guidance reaffirmed.

“regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces First-Quarter 2024 Results • Revenue of $229.0 million, an increase of 73.0% over the prior-year quarter. • Net income of $1.5 million; $0.01 per diluted share. • Adjusted Net Income of $23.7 million; $0.11 per diluted share. •”

NEOGEN CORP reported fiscal year ended May 31, 2023 results: revenue $822.4 million, net income a loss of $22.9 million, EPS $0.12 per diluted share.

“fourth quarter marked the 124th of the past 130 quarters that Neogen reported revenue increases compared to the same quarter in the prior year. Revenues for the full year were $822.4 million, an increase of 56.0% compared to $527.2 million in the prior year. Core revenue growth was 4.0% and acquisitions contributed 54.5%, while foreign currency was a headwind of”

NEOGEN CORP reported fiscal 2023 fourth quarter ended May 31, 2023 results: revenue $241.8 million, net income $5.6 million, EPS $0.03 per diluted share.

“Neogen Announces Fourth-Quarter 2023 Results • Revenue of $241.8 million, an increase of 72.6% over the prior-year quarter. • Net income of $5.6 million; $0.03 per diluted share.”

Darci Vetter resigned as Director at NEOGEN CORP.

“Darci Vetter has informed the Company that she will resign from her position as a member of the Neogen Corporation Board of Directors (the “Board”) and from all committees of the Board effective the day after the 2023 Annual Meeting of Neogen Shareholders.”

NEOGEN CORP reported Fiscal 2023 third quarter and nine months ended February 28, 2023 results: revenue $218.3 million, net income $8.2 million, EPS $0.04 per diluted share.

“report, regardless of any general incorporation language in the filing. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Neogen Announces Third-Quarter 2023 Results • Revenue of $218.3 million, an increase of 70% over the prior-year quarter. • Net income of $8.2 million; $0.04 per diluted share. • Adjusted Net Income of $26.5 million; $0.12 per diluted share. •”

NEOGEN CORP reported second quarter ended November 30, 2022 results: revenue $230.0 million, net income $(41.8) million, EPS $(0.19) per share.

“Neogen Announces Second-Quarter 2023 Results • Revenue of $230.0 million, up 76.2% over the prior-year quarter. • Net income of $(41.8) million; $(0.19) per share.”

David Naemura was appointed as Chief Financial Officer at NEOGEN CORP.

“David Naemura will be appointed as CFO of the Company, effective as of January 2, 2023”

Steve Quinlan departed as Chief Financial Officer at NEOGEN CORP.

“its Chief Financial Officer (“CFO”) Steve Quinlan will retire from his position as the Company’s CFO, effective as of May 31, 2023.”

Aashima Gupta was appointed as Class III director at NEOGEN CORP.

“increased the size of the Board from eight to ten directors and appointed Jeffrey Capello to the Board to serve as a Class I director and Aashima Gupta to the Board to serve as a Class III director.”

Jeffrey Capello was appointed as Class I director at NEOGEN CORP.

“increased the size of the Board from eight to ten directors and appointed Jeffrey Capello to the Board to serve as a Class I director and Aashima Gupta to the Board to serve as a Class III director.”

Marylinn Munson departed as Vice President, Genomics at NEOGEN CORP.

“Marylinn Munson, former Vice President, Genomics, has left the Company.”

Doug Jones was named as Chief Operating Officer at NEOGEN CORP.

“On April 19, 2022, Neogen Corporation (the “Registrant”) announced that Doug Jones was named Chief Operating Officer.”